Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Healthy adults aged 40 to under 70 at the time of consent (2) Individuals who have received a thorough explanation of the study, fully understand its purpose and procedures, voluntarily wish to participate, and provide written informed consent
Exclusion criteria
Exclusion criteria: (1) Regular use (>=3 times/week) of specified health foods, functional foods, or supplements, or inability to discontinue such products even if used less than 3 times/week (e.g., NMN, vitamins A/B/C/D/E, DHA/EPA, sesamin, protein, etc.) (2) Currently receiving pharmacological treatment at the time of consent (excluding as-needed medications) (3) Excessive alcohol consumption (average >60g/day per week) (4) Difficulty with blood sampling (5) Unable to visit the study site (6) History or current serious disease of the heart, liver, kidneys, digestive system, etc. (7) Have received a vaccination within 1 month prior to the start of the study, or have a planned vaccination during the study period (8) Allergies to medications or foods (9) Participation in another clinical study of drugs or health foods, within 4 weeks after completion of such a study, or plans to participate in another study after consenting to this one (10) Blood component or 200 mL whole blood donation within 1 month before study start (11) 400 mL whole blood donation within 3 months before study start (12) Total blood drawn within 12 months prior to study start, including planned study draws, exceeds 1200 mL (13) Determined unsuitable for participation by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biological age assessment using the Epigenetic Clock test | — |
Secondary
| Measure | Time frame |
|---|---|
| -Aging biomarkers (including NAD+, DHEA-S, 8-OHdG) -Questionnaire on aging-related factors | — |
Countries
Japan
Contacts
IMEQRD Co., Ltd Planning and Sales Department